A markedly significant decrease in moderate-to-severe episodes was found both at 4 weeks (55.6 ± 15.5 at baseline to 32.7 ± 21.1, 41.7% reduction) and 12 weeks of treatment (13.5 ± 15.8, 76.5% reduction) ( Table 3 ).
← all excerpts
Combination of Soy Isoflavones, 8-Prenylnaringenin and Melatonin Improves Hot Flashes and Health-Related Quality of Life Outcomes in Postmenopausal Women: Flavie Study.
1
—
—